CNTA

Centessa Pharmaceuticals
CNTA

Overview Fund Trends Analyst Outlook Journalist POV

50 hedge funds and large institutions have $1.05B invested in Centessa Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$398M
2
+$120M
3
+$87.3M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$43.9M
5
SB
Samsara BioCapital
California
+$34.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.22M
27
$1.78M
28
$1.49M
29
$1.39M
30
$1.31M
31
$957K
32
$926K
33
$888K
34
$839K
35
$760K
36
$686K
37
$555K
38
$409K
39
$409K
40
$222K
41
$211K
42
$110K
43
$54K
44
$47K
45
$24K
46
$24K
47
$20K
48
$15K
49
$9K
1
2